Popular Articles

China Aoxing Pharmaceutical Company Announces Completion Of Registration Trial Of Its Leading Narcotic Drug For The Treatment Of Cough
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a pharmaceutical company specializing in research, development, manufacturing and marketing of narcotic and pain-management products, announced that it has completed the registration trial with Codeine Phosphate, a compound oral solution for the treatment of acute moderate to severe cough. Top-line results from this trial are expected to be announced by the end of the third quarter of 2009.
diet pills
MicroRNAs Hold Promise For Treating Diseases In Blood Vessels
A newly discovered mechanism controls whether muscle cells in blood vessels hasten the development of both atherosclerosis and Alzheimer"s disease, according to an article published online in the journal Nature.
News of the day
Zavesca(R) (miglustat) First Treatment Available In UK And Ireland For Rare Progressive Niemann-Pick Type C Disease
Actelion Ltd (SIX: ATLN) announced the launch of Zavesca® (miglustat) in the UK and Republic of Ireland; the first and only licensed treatment available for people with Niemann-Pick type C (NP-C) disease [1]. NP-C is a rare, genetic disease with significant neurological deterioration that can be fatal and affects infants, children and adults [2,3].
Nutrition

HSPH Assistant Professor To Serve As Co-Principal Investigator Of Center In Guatemala To Combat Cardiovascular Disease

Eduardo Villamor , Assistant Professor of International Nutrition at Harvard School of Public Health (HSPH), will serve as co-principal investigator of a research and training center in Guatemala to reduce the burden of cardiovascular disease (CVD) in the Mesoamerican region, which includes Central America, the Caribbean, and Southern Mexico. "Chronic non-communicable diseases, particularly cardiovascular disease, are among the main killers in the Mesoamerican region," said Villamor. "Among our goals is to understand current risk factors for CVD in school-age children and their parents, identify ways to intervene, and train graduate students and junior investigators to carry on research." Villamor is co-principal investigator with Manuel Ramirez-Zea of the Institute of Nutrition of Central America and Panama-INCAP, Homero Martinez of RAND Corporation, Santa Monica, CA, and Benjamin Caballer of Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD. The center is part of a worldwide network of research and training centers supported by the National Heart, Lung, and Blood Institute (NHLBI) to build institutional and community capacity to prevent and control chronic diseases. In a press release, the NHLBI said that is awarding 10 contracts totaling more than $34 million. The NHLBI joins with Minneapolis-based UnitedHealth Group"s existing Chronic Disease Initiative (UnitedHealth CDI) in establishing the "UnitedHealth and NHLBI Collaborating Centers of Excellence" (COEs) network. Each COE is led by a research institution in a low- or middle-income developing country paired with at least one partner academic institution in a developed country to enhance research and training opportunities. A comment on the program, "Combating Chronic Disease in Developing Countries -- Partners in Progress," by NHLBI Director Elizabeth G. Nabel, M.D., Simon Stevens, president, Global Health, at UnitedHealth Group, and Richard Smith, M.D., director of UnitedHealth CDI, has published online today in The Lancet and will publish in the June 13 print edition (free registration is required to view the online article). The NHLBI will fund six centers in Bangladesh, China, Guatemala, India (Bangalore and New Delhi), and South Africa. These centers are also receiving funding from United Health Group"s CDI. The NHLBI is funding three additional centers in Argentina, Kenya and Peru; and United Health CDI funds two centers located at the U.S.-Mexico border and in Tunisia. Each NHLBI-funded center is also a Fogarty International Clinical Research Fellow or Scholar site. More information can be found on the NHLBI global health website. Harvard School of Public Health


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):